Orient Pharma Co., Ltd. (TPEX:4166)

Blueprint Medicines Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	200.75	84.5	83.32	76.43	130.92	49.58
Short-Term Investments	9.8	24.8	29.8	20.8	20.8	140.8
Cash & Short-Term Investments	210.55	109.3	113.12	97.23	151.72	190.38
Cash Growth	86.13%	-3.38%	16.34%	-35.92%	-20.30%	227.64%
Accounts Receivable	233.04	278.18	179.31	69.39	63.09	78.2
Other Receivables	8.49	10.36	8.16	12.91	16.82	2.35
Receivables	241.53	288.54	187.47	82.3	79.9	80.56
Inventory	280.96	279.56	233.97	194.18	156.88	138.64
Prepaid Expenses	43.94	44.12	58	39.18	30.91	14.75
Other Current Assets	9.92	6.91	29.7	10.24	19.89	9.5
Total Current Assets	786.9	728.43	622.25	423.12	439.31	433.83
Property, Plant & Equipment	879.97	891.83	944.96	903.28	769.71	792.66
Long-Term Investments	14.95	13.65	1.88	3.05	1.75	3.13
Other Intangible Assets	456.61	471.83	532.66	11.9	13.75	25.36
Long-Term Deferred Tax Assets	385.84	397.98	451.46	452.04	439.2	428.01
Other Long-Term Assets	12.83	16.87	9.47	54.18	100.1	60.82
Total Assets	2,537	2,521	2,563	1,848	1,764	1,744
Accounts Payable	52.34	36.14	55.57	61.97	19.6	28.63
Accrued Expenses	47.29	69.82	62.04	53.5	59.07	115.75
Short-Term Debt	245	250	314.5	68.5	161.5	32
Current Portion of Long-Term Debt	38.14	40	60.71	24.08	23.83	23.47
Current Portion of Leases	17.85	18.44	17.95	14.92	8.22	3.35
Current Unearned Revenue	57.14	64.51	22.01	64.87	78.07	44.73
Other Current Liabilities	7.09	8.35	30.56	63.22	69.17	2.33
Total Current Liabilities	464.86	487.25	563.35	351.06	419.46	250.25
Long-Term Debt	32.48	42.1	112.06	178.79	111.8	152.62
Long-Term Leases	191.94	195.95	211.67	221.86	109.67	112.26
Long-Term Deferred Tax Liabilities	2.62	1.84	-	-	0.13	0.01
Other Long-Term Liabilities	-	-	-	-	-	1.6
Total Liabilities	697.8	733	892.18	757.65	647.9	526.41
Common Stock	2,230	2,230	2,230	1,870	1,870	1,870
Additional Paid-In Capital	1,130	1,130	1,130	932.15	932.15	932.23
Retained Earnings	-1,529	-1,579	-1,686	-1,709	-1,682	-1,581
Comprehensive Income & Other	7.18	6.05	-3.83	-2.89	-4.6	-3.63
Shareholders' Equity	1,839	1,788	1,670	1,090	1,116	1,217
Total Liabilities & Equity	2,537	2,521	2,563	1,848	1,764	1,744
Total Debt	525.41	546.49	716.9	508.15	415.01	323.7
Net Cash (Debt)	-314.86	-437.19	-603.78	-410.92	-263.29	-133.32
Net Cash Per Share	-1.41	-1.96	-2.71	-2.20	-1.41	-0.79
Filing Date Shares Outstanding	223.04	223.04	223.04	187	187	187.01
Total Common Shares Outstanding	223.04	223.04	223.04	187	187	187.01
Working Capital	322.04	241.18	58.9	72.07	19.86	183.58
Book Value Per Share	8.25	8.01	7.49	5.83	5.97	6.51
Tangible Book Value	1,383	1,316	1,138	1,078	1,102	1,192
Tangible Book Value Per Share	6.20	5.90	5.10	5.76	5.89	6.37
Buildings	795.86	794.16	786.78	744.9	682.91	682.83
Machinery	443.91	439.37	430.96	367.95	361.11	340.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.